The technology, marketed as FerAppease in the U.S., can be used in beef and dairy animals. Economic analysis, depending on the production stage of use, offers an ROI of 20:1 to 30:1.
The CDC tested 150 practitioners last September. None of the three that had a positive serology result reported having experienced respiratory or influenza-like symptoms.
Much of the West, Southwest and upper Midwest could use more moisture. Beef and dairy producers and their veterinarians might want to do some contingency planning for what's shaping up to be a dry spring.